When evaluating and diagnosing migraines in pediatric patients, a thorough medical history is key to giving a diagnosis. These 8 questions are structured to pinpoint concerning headache patterns earlier in the diagnosing process.
Pegtarazimod data confirms inflammation biomarkers in hypoxic ischemic encephalopathy infants
In addition, data presented at PAS revealed a predictable pharmacokinetic profile in the newborn population, consistent with adult humans.
PODCAST: Auditory brain stem implants in young children.
Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.
Preterm skin-to-skin contact does not improve neurodevelopment at 2–3 years
In the immediate skin-to-skin contact group, improved breastfeeding practices up to 12 months were observed.
Preterm birth associated with long-term cognitive issues in children
Infants born moderately preterm had lower composite cognitive scores compared to those born at full-term s (β = −0.39; 95% CI, −0.55 to −0.22; P < .001).
FDA accepts sBLA to expand fremanezumab-vfrm indication for episodic migraines in children
If approved, the expanded indication would include children and adolescents aged 6 to 17 years who weigh 99 lbs (45 kg) or more.
Navepegritide NDA submitted to treat children with achondroplasia
Submission is based on 3 clinical trials, including data from the ApproaCH Trial among children with achondroplasia.